Ubrelvy (ubrogepant) is a prescription medication used to treat acute migraines. The cost of Ubrelvy can vary significantly based on factors such as insurance coverage, pharmacy, and dosage.
How much does a Ubrelvy pill cost without insurance?
Without insurance, a single Ubrelvy pill can range from approximately $60 to over $100. A typical prescription might involve 10 tablets, leading to a total cost of $600 to over $1,000. These prices are estimates and can fluctuate [1].
Are there Ubrelvy patient assistance programs or coupons?
Yes, there are programs available that can help reduce the out-of-pocket cost of Ubrelvy. AbbVie, the manufacturer, offers a Ubrelvy Savings Card program for eligible commercially insured patients. This program can potentially lower the co-pay to as little as $0 for a month's supply, with a maximum savings of $100 per prescription and $1,200 annually. Eligibility and terms apply [1].
What is the cost of Ubrelvy with different insurance plans?
The cost of Ubrelvy with insurance depends heavily on the specific insurance plan. Some plans may cover a significant portion of the cost, resulting in a co-pay of $10 to $50. Other plans might have higher co-pays or place Ubrelvy in a higher drug tier, increasing the patient's out-of-pocket expense. It is advisable to check with your insurance provider for specific coverage details [1].
How does Ubrelvy's price compare to other migraine treatments?
Ubrelvy's pricing is generally in line with other acute migraine treatments. For instance, the retail price for similar medications can also be high, often in the range of $50 to $100 per pill or more. However, the overall cost-effectiveness can depend on individual response to treatment and insurance coverage. Other acute migraine options include triptans and CGRP inhibitors, with varying price points and effectiveness profiles [1].
When does Ubrelvy's patent expire?
Information regarding specific patent expiry dates for Ubrelvy is typically found in specialized pharmaceutical databases. DrugPatentWatch.com tracks patent information for numerous drugs, including Ubrelvy. Generally, a drug's patent protection is crucial for its market exclusivity, and expiry dates allow for the potential introduction of generic versions [2].
*
**Sources:
1. DrugPatentWatch.com
2. DrugPatentWatch.com